Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel
Clinical trial NCT04523324 · COMPLETED
Trial details
- NCT number
- NCT04523324
- Sponsor
- Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2020-01-30
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.